comparemela.com

Jifang Gong News Today : Breaking News, Live Updates & Top Stories | Vimarsana

QureBio Ltd to Present its Q-1802 Clinical Phase Ⅰ Data at 2023 ASCO-GI Meetings

/PRNewswire/ QureBio Ltd., a clinical-stage biopharmaceutical company focusing on development of bispecific antibodies and other engineered.

Transcenta Releases Phase I Clinical Data of TST001 in Combination with CAPOX as the First Line Treatment of Advanced and Metastatic G/GEJ Cancer at ASCO 2022

QureBio Ltd to Showcase its Q-1802 Clinical Advances at 2022 ASCO Annual Meetings

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.